Connection
Rohit Dhall to Delayed-Action Preparations
This is a "connection" page, showing publications Rohit Dhall has written about Delayed-Action Preparations.
|
|
Connection Strength |
|
|
|
|
|
0.193 |
|
|
|
-
Dhall R, Kreitzman DL. Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety. Neurology. 2016 Apr 05; 86(14 Suppl 1):S13-24.
Score: 0.135
-
Espay AJ, Hauser RA, Dhall R, Thakkar S, Cloud L, Zeitlin L, Banisadr G, Fisher S, Visser H. Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study. Mov Disord. 2024 Feb; 39(2):428-432.
Score: 0.058